v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current Assets:    
Cash and cash equivalents $ 3,112,679 $ 1,511,188
Investments held in marketable securities 479,351 1,441,734
Accounts receivable 13,300 15,500
Prepaid expenses and other current assets 194,378 168,440
Total Current Assets 3,799,708 3,136,862
Deferred offering costs 49,808
Property and equipment, net 328,810 358,767
Intangible assets, net 511,761 534,198
Total Assets 4,640,279 4,079,635
Current Liabilities:    
Accounts payable 666,898 1,341,495
Accrued expenses and other current liabilities 947,739 982,047
Warrant liabilities 1,399,349
Total Current Liabilities 1,614,637 3,722,891
Commitments and contingencies  
Stockholders’ Equity:    
Preferred stock, $0.01 par value; 20,000,000 shares authorized; Series B Convertible Preferred Stock; 1,543,158 shares designated, 0 and 1,398,158 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 13,982
Common stock, $0.0001 par value; 75,000,000 shares authorized; 25,478,170 and 8,876,242 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 2,548 887
Additional paid-in capital 175,098,189 170,262,565
Accumulated deficit (172,075,095) (169,920,690)
Total Stockholders’ Equity 3,025,642 356,744
Total Liabilities and Stockholders’ Equity $ 4,640,279 $ 4,079,635

Source

10-Q XBRL Zip